Hologic
Hologic, Inc., a leading global medical technology company headquartered in the United States, has been at the forefront of women's health since its founding in 1982. With a strong presence in North America, Europe, and Asia, Hologic focuses on innovative solutions in the fields of diagnostics, medical imaging, and surgical products. Renowned for its advanced technologies, Hologic's core offerings include breast health, gynaecological health, and skeletal health solutions, which are distinguished by their precision and efficacy. The company has achieved significant milestones, including pioneering developments in 3D mammography and molecular diagnostics, solidifying its position as a market leader. Hologic's commitment to improving patient outcomes and enhancing healthcare efficiency has earned it numerous accolades, making it a trusted name in the medical technology industry.
DitchCarbon Score
How does Hologic's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hologic's score of 61 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hologic's reported carbon emissions
In 2024, Hologic, Inc. reported total greenhouse gas emissions of approximately 470,680,000 kg CO2e across all scopes. This includes 7,050,000 kg CO2e from Scope 1, 14,705,000 kg CO2e from Scope 2, and a significant 470,680,000 kg CO2e from Scope 3 emissions. The company has set ambitious targets to reduce its carbon footprint, aiming for a 30% reduction in Scope 1 and 2 emissions by 2030 from a 2020 baseline. Furthermore, Hologic is committed to achieving a 50% reduction in these emissions by 2030 and a 90% reduction by 2050. Hologic's long-term strategy includes reaching net-zero emissions across all scopes by 2050, with a specific commitment to reduce absolute Scope 3 emissions by 90% within the same timeframe. Additionally, the company plans to increase its sourcing of renewable electricity from 9% in FY2020 to 100% by FY2030. These targets align with the Science Based Targets initiative (SBTi) and reflect Hologic's commitment to sustainable practices in the healthcare equipment and supplies sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | - | - | - | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 000,000,000 | - | - | - | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hologic is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
